|
HS Code |
255129 |
| Species Name | Bifidobacterium adolescentis |
| Strain Type | Probiotic bacterium |
| Gram Stain | Gram-positive |
| Shape | Rod-shaped |
| Oxygen Requirement | Anaerobic |
| Natural Habitat | Human gastrointestinal tract |
| Colony Appearance | White, glossy, convex colonies |
| Optimal Growth Temperature | 37°C |
| Ph Tolerance Range | 4.5 to 7.5 |
| Carbohydrate Metabolism | Ferments various carbohydrates producing lactic and acetic acids |
| Genome Size | Approximately 2.1-2.3 Mbp |
| Health Benefits | Supports gut health, modulates immune system |
| Heat Sensitivity | Sensitive to high temperatures |
| Storage Recommendation | Refrigerated at 2-8°C |
| Application | Used in dietary supplements and fermented foods |
As an accredited Bifidobacterium Adolescentis factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, airtight plastic bottle labeled "Bifidobacterium adolescentis, 10 billion CFU, Net quantity: 60 capsules, Store in cool, dry place." |
| Shipping | Bifidobacterium adolescentis is typically shipped in lyophilized powder or frozen form, using insulated packaging with ice packs or dry ice to maintain a stable, low temperature. The shipment complies with regulations for biological substances, includes documentation, and is sent via express delivery to ensure viability upon arrival. |
| Storage | Bifidobacterium adolescentis should be stored at -20°C or lower, preferably in a tightly sealed vial or tube to prevent contamination and moisture absorption. It should be kept away from direct sunlight and heat sources. Lyophilized (freeze-dried) cultures are stable at these conditions, while active cultures require cryoprotectants and should be handled aseptically to ensure viability. |
|
Purity 99%: Bifidobacterium Adolescentis Purity 99% is used in probiotic supplement formulations, where it ensures high colonization efficiency in the intestinal tract. Viable Cell Count ≥1×10¹¹ CFU/g: Bifidobacterium Adolescentis Viable Cell Count ≥1×10¹¹ CFU/g is used in digestive health capsules, where it provides potent microbiota balancing. Stability Temperature ≤25°C: Bifidobacterium Adolescentis Stability Temperature ≤25°C is used in refrigerated dairy products, where it maintains microbial activity throughout product shelf life. Microencapsulated Form: Bifidobacterium Adolescentis Microencapsulated Form is used in powdered beverage mixes, where it delivers superior protection against gastric acidity. Particle Size ≤50 µm: Bifidobacterium Adolescentis Particle Size ≤50 µm is used in infant formula, where it promotes homogeneous distribution and absorption. Moisture Content ≤5%: Bifidobacterium Adolescentis Moisture Content ≤5% is used in freeze-dried oral sachets, where it ensures enhanced shelf stability and viability. Antibiotic Resistance Profile: Bifidobacterium Adolescentis Antibiotic Resistance Profile is used in clinical interventions, where it permits concurrent antibiotic and probiotic administration. Genetically Verified Strain: Bifidobacterium Adolescentis Genetically Verified Strain is used in research trials for irritable bowel syndrome, where it ensures strain specificity and reproducibility of results. Osmotic Tolerance ≥5% NaCl: Bifidobacterium Adolescentis Osmotic Tolerance ≥5% NaCl is used in functional fermented foods, where it guarantees robust survival during processing and storage. pH Stability Range 4.0–7.0: Bifidobacterium Adolescentis pH Stability Range 4.0–7.0 is used in acidic fruit-based matrices, where it maintains high viability during gastrointestinal transit. |
Competitive Bifidobacterium Adolescentis prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Bifidobacterium adolescentis comes out of our production lines after a detailed process that turns pure culture work into a tangible health-boosting tool. In the factory setting, each batch receives direct human attention, not just automated checks. Technicians guide the fermentation, monitor temperature trends, and verify the nutrient base so this bacterial strain grows strong and stable. Every step brings another layer of reliability, based not only on lab measurements but also on the experience we’ve built through thousands of production cycles.
Our freeze-drying section handles this living organism with hands-on care. We maintain key moisture controls because the right drying profile supports shelf survival and downstream probiotic effectiveness. Bifidobacterium adolescentis heads out the door as a beige to light-yellow powder with viable counts exceeding 1010 CFU/g, a result only possible with rigorous control at every transfer and mixing point.
Within the Bifidobacterium family, adolescentis stands out in our experience for its remarkable growth profile and digestive system support. Unlike bifidum or lactis, this strain tolerates oxygen stress during processing in ways that help us keep yields high, even with variable raw material. That makes a difference to people counting on consistent supplies for dietary supplements or functional foods.
B. adolescentis produces acetic and lactic acids as fermentation byproducts, which reinforce gut barrier function. Clients in the food and pharmaceutical fields focus on this because intestinal support goes beyond just balancing microbial populations — it also ensures metabolic byproducts aren’t drifting outside the gut. This strain’s enzyme profile draws attention for its high β-galactosidase activity, which can help people who struggle with lactose digestion.
Over decades of production, we’ve tailored our fermentation and drying procedures to produce B. adolescentis in a freeze-dried format optimized for stability and transport. In the final QC room, we confirm viability using selective agars so what leaves our site meets expectations for colony-forming units per gram. Water activity levels stay below 0.2, proven by third-party data to extend shelf life even in hot, humid climates.
We settle on a specific carrier — most often maltodextrin or skim milk — only after matching each batch of active bacteria to end-use in foods, capsules, or powders. This isn’t just done for technical reasons. We evaluate the taste, texture, and dispersibility in cold liquids, thinking about the real experience of a formulation team or the end user. We’ve learned that the optimal carrier and blend ratio varies between different strains and even from year to year, depending on global sourcing and regulation changes.
People who formulate with B. adolescentis often look for solutions to digestive discomfort or irregularity, especially in adults facing changing gut flora as they age or experience stress. From field inquiries and follow-up surveys, adult users notice smoother digestion and less bloating within a month of daily intake. While research focuses on the microbiome, as a manufacturer we also have an eye on how end-products behave in real lives. We support flavor stability trials, blend tests in milk, juice, oatmeal base, or even high-protein bars to see where this strain can go without losing viability or flavor profile over time.
Clients also appreciate how quickly B. adolescentis integrates into their pilot batches compared to other strains. We attribute that to the robust, uniform size and shape of the final dried particles we achieve, a result of close temperature management from freeze-drying. This characteristic, although not always highlighted in literature, helps reduce clumping and ensures better dispersal in finished blends.
In the fermentation hall, B. adolescentis stands apart from related strains such as longum or animalis. For our team, it’s clear even during early-stage propagation. Adolescentis adapts more readily when we switch between different carbon sources, a useful trait when running back-to-back fermentations with minimal downtime. This flexibility lets us run more predictable production cycles and supply customers year-round.
The cell wall thickness and ratio of viable to non-viable cells after drying set B. adolescentis apart on our quality-control logs. Longum usually requires a stricter moisture profile to prevent downstream viability loss, which can add to lead times in tight schedules. Adolescentis, on the other hand, stores more stably in a wider range of temperature and humidity conditions. Customers in regions with less robust cold chains ask for this strain for just that reason.
Another point of difference emerges after blending. While animalis supports certain health claims, batches often show greater clumping in granule form, sometimes demanding high-shear mixing or pre-blending with anti-caking agents. B. adolescentis behaves more smoothly, which helps our customers meet tight timelines for product launches, especially in snack or beverage lines.
Bifidobacterium adolescentis leaves our plant ready for formulation in a range of formats: single-strain powders, capsules, sachets, or as a component in multi-strain blends. Most of our customers use the bulk powder, packing it down the line into capsules or stick packs. Based on years of feedback, we recommend adding it post-pasteurization whenever possible to preserve cell count. For solid foods, especially health bars and extruded snacks, it responds well to low-temperature processes and retains over 90% viability after three months at room temperature.
A growing number of our partners in the wellness and medical nutrition fields are leveraging this strain for senior nutrition, women’s health, and specialized post-antibiotic recovery mixes. Compared to other bifidobacteria, adolescentis allows for more flexible processing temperatures and has a distinctive ability to persist in high-fiber matrices, opening the door to new synbiotic product designs. This trait comes directly from its cell wall composition and metabolic pathways we’ve mapped out over multiple fermentation cycles.
We take quality seriously, not from a compliance checklist but as a matter of legacy and pride. Technicians running real-time cultures check for contamination by off-target microbes, collect daily samples from holding tanks, and personally oversee each stage through freeze-drying and blending. Every time product leaves our facility, it carries a record of the exact strains seeded, fermentation dates, and viability tests — something our long-term partners value because it supports regulatory submissions or export audits.
We monitor allergen contamination tightly, knowing even trace milk or soy residues can impact sensitive users. Cross-contamination controls, frequent hand-off checks, and physical separation in plant zones prevent any mix-up between B. adolescentis and other probiotic strains. We keep our own archives of each batch in sealed vials, long after shipment, so we can answer questions or run stability tests on actual product, not just on samples.
Reliable shelf life remains one of the central challenges for any probiotic supplier. Bifidobacterium adolescentis holds up during normal warehouse storage at ambient temperature, but we urge careful attention to container choice and humidity. Customers who invest in moisture-barrier packaging and keep the product in moderate conditions report CFU counts well above labeling even after twelve months. In contrast, exposure to uncontrolled warehouse heat or oxygen spikes can degrade quality rapidly, so we share detailed storage protocols with distributors and blend houses.
Supply chain interruptions present another ongoing hurdle, especially for global customers who must navigate sudden logistics or customs slowdowns. We maintain multiple starter pools and backup stock of carriers for B. adolescentis, so we have options in place when shortages hit. Our in-house team adapts load schedules and communicates directly with customer procurement, providing transparency if raw material timelines shift.
World regulations shift fast, particularly for probiotics moving between food and supplement categories. Based on feedback from regulatory teams, B. adolescentis enjoys wider acceptance in health claims and labeling, thanks to a robust dossier of safety and performance studies. We partner with academic labs for documentation rather than relying solely on internal data, knowing third-party validation carries more weight in international markets. We supply Material Safety Data Sheets, strain origin certificates, and non-GMO statements up front, so customer teams don’t get bogged down during product development or regulatory checks.
Input from customers — formulators, QA teams, manufacturers, and end users — changes how we work with Bifidobacterium adolescentis month by month. We catalog every batch result and analyze trends, whether it’s a noted difference in taste from a new maltodextrin supplier or a spike in shelf life after a process tweak. Several years ago, direct calls from users in Southeast Asia led us to tighten up humidity controls and invest in vacuum-sealed packaging lines.
Some customers have shared outcomes from blinded studies: participants taking blends with B. adolescentis report less gastrointestinal upset and more regular bowel habits. They also note improved taste when compared to blends using other bifido strains, a point confirmed by a growing number of sensory panels. We document all this, learning as much from negative feedback as from endorsements. Each year, this living record influences which suppliers we work with, which production steps we automate, and which areas we invest in for training.
Technical questions often come up about heat tolerance, blending sequence, or ideal reconstitution temperature for ready-to-drink uses. Over time, we’ve provided direct, practical advice — for instance, emphasizing that this strain sees best results if added below 40°C and processed as late as possible during formulation. We do this not to protect a trade secret, but because supplying accurate, experience-based information keeps manufacturers competitive.
Thanks to its consistent survival and gentle processing tolerance, B. adolescentis supports clean-label trends. Formulators aiming for minimal ingredient lists use this strain because they don’t need to load up with stabilizers, anti-caking agents, or flavor masking. As a result, products look better to discerning consumers and avoid triggering the “unpronounceable ingredient” reaction that blocks so many launches.
Current research shows B. adolescentis as naturally dairy-free for most production methods, so vegan and plant-based brands use it readily as part of their functional foods. Our team tracks carrier origins, updates allergen documentation, and runs continual checks for common cross-contacts, ensuring food safety teams get what they expect every time.
We work with B. adolescentis not just as a product, but as the result of decades of global study in gut microbiome science. Large-scale meta-analyses and clinical trial results show real benefits for digestion, immune system support, and microbial balance. We have observed a growing number of customers use this strain as a core part of products marketed for irritable bowel relief, general gut health, and even targeted health claims for adult and senior populations.
No other strain we handle offers the same mix of storage stability and consumer-reported digestive comfort. Direct supplier data echoes our experience, showing minimal loss in live cell counts even in shelf-stable foods where other probiotics often fade below label claim before expiration.
Manufacturers and research partners keep pushing Bifidobacterium adolescentis into new territory. Synbiotic blends — combining this strain with select prebiotics such as FOS, GOS, or inulin — now dominate our custom formulation requests. The result: enhanced survival across gut transit and higher colonization rates, a fact backed up by both digestive health studies and direct batch monitoring.
Collaborative work between our team and external R&D consultants focuses on improving cell wall resilience through tailored nutrient feed, extending shelf life, and reducing clumping without additives. Through open discussions and shared troubleshooting, we keep refining formulations based on end-user data, not just internal target numbers.
We see B. adolescentis as a living bridge between strict manufacturing controls and consumer wellness trends. It thrives on practical feedback — the comments from an R&D manager in Tokyo, the QC data from a Los Angeles nutraceutical blender, or the shelf-life tracking results from a retail partner in São Paulo. That collective knowledge informs every step of our process, from inoculation to package seal.
We make targeted choices about energy use, water recycling, and waste management during B. adolescentis production. We’ve moved to closed fermentation tanks with advanced temperature recovery to cut heating and cooling demand. We operate a live monitor of water inputs and worked with our engineering team to establish recycling protocols for non-contact process water.
Plant-level changes extend into supply chain partnerships, favoring packaging suppliers who use post-consumer recycled content and shippers invested in refrigeration efficiency. As environmental regulations grow, these steps become more important for our continued operation. Customers developing products for global or “eco” markets want a transparent record of how the probiotic was made, so we keep proactive documentation of each improvement.
We see this responsibility not as a marketing claim but as an operational necessity. Bifidobacterium adolescentis forms part of health-forward product portfolios — maintaining consumer trust means adopting environmentally and ethically sound production practices, not just following minimal standards.
Longstanding familiarity with this strain gives us steady confidence, both for ourselves as producers and for our end customers. Years of laboratory and real-world testing demonstrate Bifidobacterium adolescentis as reliable, flexible, and easy to work into a variety of applications. As trends shift — whether toward convenience nutrition, targeted probiotics, or wider international distribution — most new demands can be met by refining the same proven approach we use for this product.
With every batch, we bring together hands-on production experience, global research insights, and lessons from practical user feedback. Bifidobacterium adolescentis continues to meet the high standards required for functional foods, dietary supplements, and medical nutrition products worldwide. By listening to product developers, solving storage and blending obstacles, and adapting production to real-world conditions, we make this probiotic a trusted solution for users across the supply chain.